ロード中...
Complex Crystal Structures of EGFR with Third-Generation Kinase Inhibitors and Simultaneously Bound Allosteric Ligands
[Image: see text] Osimertinib is a third-generation tyrosine kinase inhibitor (TKI) and currently the gold-standard for the treatment of patients suffering from non-small cell lung cancer (NSCLC) harboring T790M-mutated epidermal growth factor receptor (EGFR). The outcome of the treatment, however,...
保存先:
| 出版年: | ACS Med Chem Lett |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Chemical
Society
2020
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7734789/ https://ncbi.nlm.nih.gov/pubmed/33335671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.0c00472 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|